Cite
HARVARD Citation
Iizumi, T. et al. (2022). Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer. Journal of medical radiation sciences. 69 (2), pp. 198-207. [Online].